Vulvovaginal candidiasis(VVC)
Conditions
Interventions
Experimental group:Bao fu Kang suppository
control group: miconazole nitrate suppositories
Sponsors
Shandong Provincial Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. There were typical clinical symptoms and signs of VVC; 2. The vaginal secretions were positive for fungal microscopy; 3. The score of VVC clinical symptoms and signs was <7 points; 4. Aged <50 years old with sexual life, non menopausal women.
Exclusion criteria
Exclusion criteria: 1. suffering from other vaginitis (BV/AV/TV/CV) affecting the curative effect evaluation, or suspected gonorrhea and simplicity,herpes virus infection and other vulvar diseases; 2. Systemic or vaginal antifungal or antibiotic treatment was received within the first two weeks; 3. Pregnant women, lactating women and pregnant women; 4. women with liver and kidney dysfunction, low immune function, diabetes, mental illness or other serious diseases; 5. Allergic constitution and patients who are allergic to this drug ingredient; 6. poor compliance; 7. Patients who did not use condoms during the treatment period; 8. RVVC or severe VVC.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of symptoms and signs;The improvement of vagina Microecology;The improvement of vagina Microecology; | — |
Countries
China
Contacts
Public ContactChenrong
Hainan Bikai pharmaceutical co., LTD
Outcome results
None listed